Symptom-limited Stair Climbing Test in Heart Failure

NCT04352426 | Completed

• 1 other identifier: busra.alkan
• Study Type: observational
• Target: 31
• Locations: 0 countries
• Sites: N/A

Brief Summary

Aims: To assess the efficacy of symptom-limited stair-climbing test (SLSCT), in determining the exercise capacities of patients with chronic heart failure (CHF) in comparison with cardiopulmonary exercise test (CPET) and 6-minute walk test(6MWT) and to interpret the results according to the clinical status of the patients. Methods: Thirty-one patients, aged 50-75 years, with stage II-III CHF according to the New York Heart Association Classification and left ventricular ejection fraction (LVEF) of ≤45% were included. The demographic and clinical characteristics of the patients were recorded. Exercise capacity was assessed by SLSCT, 6MWT, and CPET. The duration of patients' performance in the test, reasons for ending the test and predicted maximal oxygen consumption (VO2max) were recorded. Heart rate (HR), blood pressure (BP), dyspnoea severity \[Modified Borg Scale (MBS)\] and peripheral oxygen saturation were recorded. Pulmonary functions were assessed by spirometry.

Conditions

Chronic Heart Failure

Keywords

chronic heart failure; exercise capacity; symptom-limited stair-climbing test

Outcome Measures

Primary Outcomes (3)

• Symptom-Limited Stair-Climbing Test(SLSCT)

  predicted VO2 max (ml/kg/min)

  baseline

• Six-Minute Walk Test(6MWT)

  predicted VO2 max (ml/kg/min)

  baseline

• Cardiopulmonary Exercise Test(CPET)

  predicted VO2 max (ml/kg/min)

  baseline

Secondary Outcomes (3)

• Heart Rate

  immediately after the procedure

• Left Ventricular Ejection Fraction

  baseline

• Blood Pressure

  immediately after the procedure

Other Outcomes (9)

• FVC l/sec

  baseline

• FEF 25-75 l/sec

  baseline

• PEF l/sec

  baseline

Interventions

Exercise Test OTHER

Tests were conducted to evaluate exercise capacity.

Eligibility Criteria

• Age: 50 Years - 75 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Thirty-one patients age 65.52±7.57 years with stage II-III according to the NYHA classification, diagnosed with CHF, with a LVEF of 45% or less admitted to study.

You may qualify if:

• years of age
• NYHA stage II-III
• LVEF of 45% or less
• Independently walking and climbing stairs
• Volunteer to participate in research

You may not qualify if:

• Any acute or chronic condition that would limit exercise capacity other than CHF
• Insufficient mental status to perform tests and surveys
• Orthopaedic problem limiting exercise test in lower extremity
• Severe obesity or there is a secondary cause for obesity
• Uncontrolled cardiac arrhythmia
• Unstable angina

Sponsors & Collaborators

• KTO Karatay University: lead

MeSH Terms

Interventions

Exercise Test

Intervention Hierarchy (Ancestors)

Heart Function Tests; Diagnostic Techniques, Cardiovascular; Diagnostic Techniques and Procedures; Diagnosis; Respiratory Function Tests; Diagnostic Techniques, Respiratory System; Ergometry; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 6, 2020
• First Posted: April 20, 2020
• Study Start: January 13, 2017
• Primary Completion: November 10, 2017
• Study Completion: November 12, 2017
• Last Updated: April 20, 2020

Record last verified: 2020-04